The ketogenic diet: an appropriate first-line therapy?

Click to increase image sizeClick to decrease image size

Acknowledgements

The author gratefully acknowledges the content review by Gerry Harris.

Financial & competing interests disclosure

Eric H Kossoff is on the Scientific Advisory Board of Atkins Nutritionals, Inc. He has research support for a clinical study from Nutricia, Inc., related to their product KetoCal^®. The author has no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

No writing assistance was utilized in the production of this manuscript.